Exendin-4 decreases liver inflammation and atherosclerosis development simultaneously by reducing macrophage infiltration.
Wang Y, Parlevliet ET, Geerling JJ, van der Tuin SJ, Zhang H, Bieghs V, Jawad AH, Shiri-Sverdlov R, Bot I, de Jager SC, Havekes LM, Romijn JA, Willems van Dijk K, Rensen PC.
Wang Y, et al.
Br J Pharmacol. 2014 Feb;171(3):723-34. doi: 10.1111/bph.12490.
Br J Pharmacol. 2014.
PMID: 24490861
Free PMC article.